Plasmodium vivax malaria vaccine development (Q34462082)

2 August 2017

1 reference

title

Plasmodium vivax malaria vaccine development (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Plasmodium vivax malaria

1 reference

1 reference

Arévalo-Herrera M

1 reference

2 August 2017

Herrera S

series ordinal

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

443-455

1 reference

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antigenic diversity in Thai Plasmodium vivax circumsporozoite proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Plasmodium vivax, P. cynomolgi, and P. knowlesi: identification of homologue proteins associated with the surface of merozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Characterization of naturally acquired antibodies to the non-repetitive flanking regions of the circumsporozoite protein of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The population dynamics in mosquitoes and humans of two Plasmodium vivax polymorphs distinguished by different circumsporozoite protein repeat regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Malaria transmission-blocking vaccines--how can their development be supported?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Molecular insights into receptors used by malaria parasites for erythrocyte invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Peptide-primed CD4+ cells and malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

DNA Cloning ofPlasmodium falciparumCircumsporozoite Gene: Amino Acid Sequence of Repetitive Epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Prevalence of Antibody to the Variant Repeat of the Circumsporozoite Protein of Plasmodium Vivax in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Plasmodium vivax merozoite surface protein-3 contains coiled-coil motifs in an alanine-rich central domain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Plasmodium vivax merozoite surface proteins-3beta and-3gamma share structural similarities with P. vivax merozoite surface protein-3alpha and define a new gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Saccharomyces cerevisiae-Secreted Fusion Proteins Pfs25 and Pfs28 Elicit PotentPlasmodium falciparumTransmission-Blocking Antibodies in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Malaria vaccines-targeting infected hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Immunogenicity of Plasmodium falciparum sexual stage antigens: Implications for the design of a transmission blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The analysis of circumsporozoite-protein gene sequences from South Korean isolates of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The Plasmodium cynomolgi merozoite surface protein 1 C-terminal sequence and its homologies with other Plasmodium species

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Presence of antibody to a heterologous circumsporozoite protein of Plasmodium vivax (VK247) in southeastern Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Sequence variation in the circumsporozoite protein gene of Plasmodium vivax appears to be regionally biased

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The neglected burden of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Malaria vaccine: Immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antibodies to Sporozoites: Their Frequent Occurrence in Individuals Living in an Area of Hyperendemic Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Inhibitory activity of IL-6 on malaria hepatic stages.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Interallelic recombination in the merozoite surface protein 1 (MSP-1) gene of Plasmodium vivax from Thai isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Polymorphism in the circumsporozoite protein of the human malaria parasite Plasmodium vivax.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

CD8+ T-cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Cloning and expression of the thrombospondin related adhesive protein gene of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Characterization of Plasmodium falciparum sporozoite surface protein 2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Interleukin 12 induction of interferon gamma-dependent protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Thrombospondin-related adhesive protein (TRAP) of Plasmodium berghei and parasite motility

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Chimpanzees and supporting models in the study of malaria pre-erythrocytic stages

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

CD4+ cytolytic T cell clone confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

The dynamics of drug resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Drug resistant Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Field evaluation of enzyme-linked immunosorbent assays for Plasmodium falciparum and Plasmodium vivax sporozoites in mosquitoes (Diptera: Culicidae) from Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Prevalence of antibody to heterologous circumsporozoite protein of Plasmodium vivax in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900080-3

7 January 2021

10.1016/S0161-5890(01)00080-3

Identifiers

DOI

1 reference

2 August 2017

1 reference